Marie W. Munch

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Empirical Meropenem Versus Piperacillin/Tazobactam for Critically Ill Adults With Sepsis: Feasibility of a Randomised Trial.

Empirical Meropenem Versus Piperacillin/Tazobactam for Critically Ill Adults With Sepsis: Feasibility of a Randomised Trial.

Journal: Acta anaesthesiologica Scandinavica
Published: July 03, 2026

Use of piperacillin/tazobactam and meropenem in a Danish intensive care unit.

Use of piperacillin/tazobactam and meropenem in a Danish intensive care unit.

Journal: Danish medical journal
Published: March 21, 2025

INCEPT: The Intensive Care Platform Trial-Design and protocol.

INCEPT: The Intensive Care Platform Trial-Design and protocol.

Journal: Acta anaesthesiologica Scandinavica
Published: February 27, 2025

Hyperglycemia and insulin use in patients with COVID-19 and severe hypoxemia allocated to 12 mg vs. 6 mg of dexamethasone: a secondary analysis of the COVID STEROID 2 randomized trial.

Hyperglycemia and insulin use in patients with COVID-19 and severe hypoxemia allocated to 12 mg vs. 6 mg of dexamethasone: a secondary analysis of the COVID STEROID 2 randomized trial.

Journal: Annals of intensive care
Published: November 12, 2024

Serious adverse events reporting in recent randomised clinical trials in intensive care medicine - A methodological study protocol.

Serious adverse events reporting in recent randomised clinical trials in intensive care medicine - A methodological study protocol.

Journal: Acta anaesthesiologica Scandinavica
Published: July 31, 2024

Empirical meropenem versus piperacillin/tazobactam for adult patients with sepsis (EMPRESS) trial: Protocol.

Empirical meropenem versus piperacillin/tazobactam for adult patients with sepsis (EMPRESS) trial: Protocol.

Journal: Acta anaesthesiologica Scandinavica
Published: April 16, 2024

Empirical carbapenems or piperacillin/tazobactam for infections in intensive care: An international retrospective cohort study.

Empirical carbapenems or piperacillin/tazobactam for infections in intensive care: An international retrospective cohort study.

Journal: Acta anaesthesiologica Scandinavica
Published: January 24, 2024

Title Not Found

Title Not Found

Journal: Ugeskrift for laeger
Published: October 24, 2023

Dexamethasone doses in patients with COVID-19 and hypoxia: A systematic review and meta-analysis.

Dexamethasone doses in patients with COVID-19 and hypoxia: A systematic review and meta-analysis.

Journal: Acta anaesthesiologica Scandinavica
Published: July 06, 2023

Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia - a post hoc evaluation of the COVID STEROID 2 trial.

Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia - a post hoc evaluation of the COVID STEROID 2 trial.

Journal: The Lancet regional health. Southeast Asia
Published: April 24, 2023

Use of days alive without life support and similar count outcomes in randomised clinical trials - an overview and comparison of methodological choices and analysis methods.

Use of days alive without life support and similar count outcomes in randomised clinical trials - an overview and comparison of methodological choices and analysis methods.

Journal: BMC medical research methodology
Published: February 15, 2023

Causal Bayesian machine learning to assess treatment effect heterogeneity by dexamethasone dose for patients with COVID-19 and severe hypoxemia.

Causal Bayesian machine learning to assess treatment effect heterogeneity by dexamethasone dose for patients with COVID-19 and severe hypoxemia.

Journal: Scientific reports
Published: January 03, 2023
Showing 1-12 of 29

Last Updated: 09/26/2026